|
|
Article: U.S. Patent Disclosures.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Acusphere Inc., of Watertown, Mass., received U.S. Patent No. 6,730,322 titled "Matrices Formed of Polymer and Hydrophobic Compounds for Use in Drug Delivery."
Adherex Technologies Inc., of Ottawa, Ontario, was issued U.S. Patent No. 6,723,700, a composition-of-matter patent for compounds that modulate the family of adhesion molecules known as claudins, which have applications such as enhancing the delivery of drugs to tumors and the inhibition of angiogenesis.
AMDL Inc., of Tustin, Calif., received a patent for its Combination Immunogene Therapy, which uses two genes in combination to build a body's immune system and destroy cancer cells.
...